URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Jane Liesveld

Concepts (582)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Leukemia, Myeloid, Acute
20
1988
172
4.320
Why?
Hematopoietic Stem Cells
19
1989
196
3.120
Why?
Bone Marrow Transplantation
18
1993
189
2.720
Why?
Stem Cell Transplantation
7
1993
108
2.320
Why?
Antigens, CD34
22
1989
51
2.190
Why?
Hematopoietic Stem Cell Transplantation
15
1998
124
2.180
Why?
Leukemia
12
1991
152
2.130
Why?
Antineoplastic Agents
13
1999
598
2.000
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
11
1993
56
1.870
Why?
Antineoplastic Combined Chemotherapy Protocols
19
1993
409
1.770
Why?
Leukemia, Myeloid
9
1988
115
1.750
Why?
Hematopoiesis
11
1986
128
1.570
Why?
Bone Marrow Cells
15
1989
220
1.530
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
10
1993
79
1.430
Why?
Myelodysplastic Syndromes
5
2001
129
1.300
Why?
Humans
111
1986
35000
1.230
Why?
Hematopoietic Stem Cell Mobilization
5
2000
14
1.180
Why?
Apoptosis
9
1996
782
1.100
Why?
Boronic Acids
4
2005
25
1.100
Why?
Pyrazines
4
2005
29
1.090
Why?
Lymphoma, Non-Hodgkin
8
1988
105
1.040
Why?
Adult
55
1988
10906
0.990
Why?
Heterocyclic Compounds
4
2004
15
0.980
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
1999
82
0.970
Why?
Transplantation, Homologous
14
1995
261
0.970
Why?
Middle Aged
47
1988
9461
0.910
Why?
Stem Cells
5
1986
338
0.900
Why?
Hematopoietic Cell Growth Factors
7
1993
14
0.900
Why?
Graft vs Host Disease
9
1999
92
0.870
Why?
Thrombocytopenia
3
1987
71
0.850
Why?
Antigens, CD
13
1991
240
0.850
Why?
Cytokines
9
1988
555
0.830
Why?
Neoplastic Stem Cells
6
1994
40
0.830
Why?
Hodgkin Disease
6
1993
152
0.820
Why?
Leukemia, Promyelocytic, Acute
2
2006
26
0.820
Why?
Receptors, Thrombopoietin
1
2012
7
0.820
Why?
Hydrazines
1
2012
13
0.820
Why?
Benzoates
1
2012
15
0.810
Why?
Cell Survival
5
1989
537
0.800
Why?
Pyrazoles
1
2012
56
0.790
Why?
Stromal Cells
4
1996
69
0.770
Why?
Granulocyte Colony-Stimulating Factor
6
1993
42
0.770
Why?
Protease Inhibitors
1
2011
42
0.760
Why?
Cell Adhesion
10
1988
253
0.750
Why?
Female
54
1988
19061
0.730
Why?
Molecular Targeted Therapy
1
2010
20
0.730
Why?
Registries
2
2008
203
0.720
Why?
Integrins
3
1993
45
0.710
Why?
Neoplasm Proteins
4
1994
164
0.700
Why?
Aged
35
1988
6986
0.690
Why?
Quinolones
3
2001
24
0.670
Why?
Cell Movement
4
2001
352
0.670
Why?
Transplantation, Autologous
13
1993
136
0.670
Why?
Bone Marrow
12
1986
282
0.660
Why?
Cytarabine
8
1998
82
0.650
Why?
Transplantation Chimera
2
2005
26
0.650
Why?
Male
51
1988
18870
0.640
Why?
Tumor Cells, Cultured
12
1991
871
0.640
Why?
Transplantation Tolerance
1
2008
3
0.630
Why?
Chromosomes, Human, Y
1
2008
4
0.630
Why?
Graft vs Tumor Effect
1
2008
7
0.630
Why?
Graft Rejection
2
2005
142
0.610
Why?
Pyrimidines
4
2007
64
0.590
Why?
Thrombocythemia, Essential
1
2007
6
0.580
Why?
Janus Kinase 2
1
2007
13
0.570
Why?
Peripheral Blood Stem Cell Transplantation
3
2002
20
0.560
Why?
Cell Communication
2
2000
135
0.560
Why?
Treatment Outcome
16
1993
2487
0.540
Why?
Alkyl and Aryl Transferases
2
2001
10
0.540
Why?
Eosinophilia
3
1988
31
0.540
Why?
Methylprednisolone
2
1999
44
0.520
Why?
Neoplasms
4
2002
701
0.510
Why?
Graft Survival
3
2000
145
0.510
Why?
Coculture Techniques
5
1996
86
0.500
Why?
Hydroxyquinolines
3
1993
9
0.490
Why?
Antiviral Agents
2
2002
181
0.490
Why?
Lymphoma
4
1993
151
0.490
Why?
Antibodies, Monoclonal, Murine-Derived
5
2009
124
0.480
Why?
Farnesyltranstransferase
4
2001
13
0.470
Why?
Colony-Forming Units Assay
7
1988
37
0.470
Why?
Combined Modality Therapy
13
1991
459
0.460
Why?
Prognosis
9
1993
1030
0.460
Why?
Enzyme Inhibitors
2
2001
396
0.460
Why?
Imagery (Psychotherapy)
1
2003
3
0.450
Why?
Antigens, CD18
3
1991
23
0.450
Why?
Music Therapy
1
2003
4
0.450
Why?
Relaxation Therapy
1
2003
15
0.450
Why?
Adolescent
19
1993
4513
0.450
Why?
Quercetin
1
2003
14
0.440
Why?
Cord Blood Stem Cell Transplantation
1
2003
5
0.430
Why?
Endothelial Cells
1
2005
173
0.430
Why?
Stem Cell Factor
5
1993
15
0.430
Why?
Piperazines
3
2007
71
0.430
Why?
Piperidines
1
2003
41
0.430
Why?
Mice, SCID
5
2003
170
0.430
Why?
Blood Donors
1
2003
27
0.420
Why?
Time Factors
10
1991
3047
0.420
Why?
Acute Disease
9
1996
570
0.420
Why?
Flavonoids
1
2003
64
0.420
Why?
Cell Separation
4
1994
224
0.410
Why?
Survival Analysis
11
1993
575
0.410
Why?
Disease-Free Survival
11
1995
191
0.410
Why?
Mice, Inbred NOD
4
2003
37
0.410
Why?
Cell Differentiation
7
1991
1021
0.400
Why?
Transforming Growth Factor beta
3
1993
362
0.400
Why?
Growth Substances
3
1996
96
0.400
Why?
Valine
1
2002
32
0.390
Why?
Acyclovir
1
2002
42
0.390
Why?
Multiple Myeloma
3
2004
73
0.390
Why?
Antibodies, Monoclonal
9
1986
725
0.390
Why?
Herpes Simplex
1
2002
47
0.390
Why?
Retrospective Studies
13
1991
2167
0.370
Why?
Survival Rate
12
1991
584
0.360
Why?
Macrophage Inflammatory Proteins
1
2000
23
0.360
Why?
Chemokines
1
2001
112
0.360
Why?
Stomatitis
2
1999
15
0.360
Why?
Cell Cycle
4
1994
247
0.350
Why?
Child
12
1995
3897
0.340
Why?
Cell Line, Tumor
4
2005
543
0.340
Why?
Remission Induction
9
1996
155
0.340
Why?
Parenteral Nutrition
1
1999
23
0.340
Why?
Nifedipine
1
1999
33
0.340
Why?
Lymphoma, Large B-Cell, Diffuse
2
2009
72
0.340
Why?
Receptors, Fc
2
1988
70
0.340
Why?
Neoplasm Recurrence, Local
3
2009
272
0.330
Why?
Drug Resistance, Neoplasm
3
1996
54
0.330
Why?
Methotrexate
1
1999
73
0.330
Why?
Mouth Mucosa
1
1999
43
0.330
Why?
Tissue Preservation
1
1999
20
0.330
Why?
Cyclosporine
1
1999
61
0.330
Why?
Lymphoma, Follicular
2
1991
54
0.330
Why?
Calcium Channel Blockers
1
1999
66
0.330
Why?
Immunosuppressive Agents
2
1999
200
0.320
Why?
Recurrence
10
1993
656
0.320
Why?
Immunotherapy
2
1994
88
0.310
Why?
Child, Preschool
9
1997
2452
0.310
Why?
Amifostine
2
2004
25
0.300
Why?
Nuclear Proteins
2
1994
333
0.300
Why?
Phenotype
4
1989
727
0.290
Why?
Parvoviridae Infections
2
1993
12
0.290
Why?
Interleukin-1
4
1988
204
0.290
Why?
Cell Adhesion Molecules
2
1994
66
0.290
Why?
Vidarabine
2
2005
27
0.280
Why?
Antilymphocyte Serum
3
2005
26
0.280
Why?
Cells, Cultured
7
1989
2367
0.280
Why?
Nitric Oxide
1
1999
239
0.280
Why?
B-Lymphocytes
3
1990
460
0.280
Why?
Interleukin-3
4
1991
40
0.270
Why?
Leukemia, Megakaryoblastic, Acute
1
1996
10
0.270
Why?
Mice
9
1995
5900
0.270
Why?
Etoposide
4
1998
73
0.270
Why?
Drug Resistance, Multiple
1
1996
26
0.260
Why?
Dendritic Cells
2
2002
110
0.260
Why?
ABO Blood-Group System
3
2003
66
0.260
Why?
Oxygen
1
1999
476
0.260
Why?
Endothelium, Vascular
2
1994
401
0.260
Why?
Tretinoin
1
2006
93
0.260
Why?
Neutrophils
1
1998
307
0.260
Why?
Cell Proliferation
2
2007
480
0.260
Why?
Follow-Up Studies
5
1997
1757
0.260
Why?
Platelet Transfusion
2
2005
84
0.250
Why?
Databases, Factual
2
1999
147
0.250
Why?
Carmustine
3
1998
35
0.250
Why?
Animals
13
1992
15647
0.240
Why?
Tumor Necrosis Factor-alpha
5
1993
627
0.240
Why?
Extracellular Matrix
3
1989
155
0.240
Why?
Flow Cytometry
7
1990
597
0.230
Why?
Cell Division
4
1996
735
0.230
Why?
Macrophages
2
1991
329
0.230
Why?
Gene Expression Regulation, Neoplastic
1
2006
247
0.230
Why?
E-Selectin
2
1994
17
0.230
Why?
Giant Cells
1
1993
11
0.230
Why?
Antigens, Differentiation
2
1989
64
0.220
Why?
Histiocytoma, Benign Fibrous
1
1993
21
0.220
Why?
Dose-Response Relationship, Drug
7
2000
1085
0.220
Why?
Transplantation Conditioning
2
2010
33
0.220
Why?
Antigens, Neoplasm
1
1994
105
0.220
Why?
Infant
6
1999
2102
0.220
Why?
AIDS-Related Complex
1
1993
14
0.210
Why?
Caspase 3
2
2003
86
0.210
Why?
Blast Crisis
3
2006
20
0.210
Why?
Parvovirus B19, Human
1
1993
6
0.210
Why?
Erythroid Precursor Cells
1
1993
11
0.210
Why?
Granulocytes
2
1989
80
0.210
Why?
Receptors, CXCR4
2
2001
24
0.210
Why?
Red-Cell Aplasia, Pure
1
1993
9
0.210
Why?
Hematologic Neoplasms
3
1999
34
0.210
Why?
Caspases
2
2003
98
0.210
Why?
Cytoprotection
2
2004
35
0.210
Why?
Erythropoiesis
2
1987
65
0.210
Why?
Platelet Count
1
2012
46
0.200
Why?
Glucocorticoids
2
1987
159
0.200
Why?
Antibodies
3
1993
207
0.200
Why?
Colony-Stimulating Factors
2
1988
27
0.200
Why?
Fatal Outcome
1
2012
101
0.200
Why?
Antibody-Dependent Cell Cytotoxicity
2
1986
28
0.200
Why?
Abnormal Karyotype
1
2011
1
0.200
Why?
Benzenesulfonates
1
2011
7
0.190
Why?
Arsenicals
1
2011
7
0.190
Why?
Azacitidine
1
2011
17
0.190
Why?
Oxides
1
2011
21
0.190
Why?
Chromosomes, Human, Pair 5
1
2011
9
0.190
Why?
Thalidomide
1
2011
13
0.190
Why?
Case-Control Studies
2
2003
587
0.190
Why?
Gastrointestinal Tract
1
2011
26
0.190
Why?
Adverse Drug Reaction Reporting Systems
1
2010
6
0.190
Why?
Lambert-Eaton Myasthenic Syndrome
1
1991
3
0.190
Why?
Antigens, CD11
2
1991
3
0.190
Why?
P-Selectin
2
2007
20
0.190
Why?
Chromosome Deletion
1
2011
62
0.190
Why?
Nitrogen Mustard Compounds
1
2011
17
0.180
Why?
Pyridines
1
2011
73
0.180
Why?
Sesquiterpenes
2
2007
19
0.180
Why?
Lymphoma, Mantle-Cell
1
2011
16
0.180
Why?
Cohort Studies
5
2001
912
0.180
Why?
Culture Media
2
1988
190
0.170
Why?
Recombinant Proteins
5
1988
706
0.170
Why?
Kinetics
3
1991
1377
0.170
Why?
Bone Marrow Diseases
2
1995
38
0.170
Why?
Melphalan
2
2004
27
0.170
Why?
Toll-Like Receptor 9
1
2009
10
0.170
Why?
Biomimetic Materials
1
2009
3
0.170
Why?
T-Lymphocyte Subsets
2
1994
111
0.170
Why?
Blood Component Removal
1
2009
11
0.170
Why?
Lymphocytosis
1
2009
12
0.160
Why?
TNF-Related Apoptosis-Inducing Ligand
1
2009
14
0.160
Why?
Analysis of Variance
3
1999
705
0.160
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
1991
125
0.160
Why?
Interleukin-7
3
1994
10
0.160
Why?
Blood Cell Count
3
1987
44
0.160
Why?
Erythrocyte Transfusion
2
2005
58
0.160
Why?
Pilot Projects
3
2001
426
0.160
Why?
Genetic Diseases, Inborn
1
2008
17
0.160
Why?
Skin Neoplasms
1
2011
225
0.160
Why?
Immunophenotyping
4
1993
123
0.160
Why?
Thiazoles
1
2009
85
0.150
Why?
T-Lymphocytes, Cytotoxic
1
2009
130
0.150
Why?
Killer Cells, Natural
1
2009
122
0.150
Why?
Protein Kinase Inhibitors
1
2009
91
0.150
Why?
Pelger-Huet Anomaly
1
1988
1
0.150
Why?
Hydrocortisone
1
1988
131
0.150
Why?
Biological Agents
1
1988
21
0.150
Why?
Soft Tissue Neoplasms
1
2008
41
0.150
Why?
Karyotyping
3
2006
107
0.150
Why?
Whole-Body Irradiation
4
1995
78
0.150
Why?
Sarcoma
1
2008
59
0.150
Why?
Thiadiazoles
1
2007
13
0.150
Why?
DNA Mutational Analysis
1
2008
185
0.150
Why?
Interleukin-2
1
1988
198
0.150
Why?
Translocation, Genetic
1
2007
62
0.150
Why?
Philadelphia Chromosome
1
2007
11
0.140
Why?
Predictive Value of Tests
3
1993
579
0.140
Why?
HIV-1
1
1993
544
0.140
Why?
Chemokine CXCL12
1
2007
33
0.140
Why?
Anemia, Hemolytic, Autoimmune
1
1987
22
0.140
Why?
Skin Diseases
1
2008
120
0.140
Why?
Reticulocytes
1
1987
46
0.140
Why?
Liver
1
2011
870
0.140
Why?
Amnesia, Anterograde
1
2006
1
0.140
Why?
Cyclophosphamide
3
1998
169
0.140
Why?
Obesity
1
2010
301
0.140
Why?
Adjuvants, Immunologic
2
1993
118
0.140
Why?
Central Nervous System Depressants
1
2006
10
0.140
Why?
Phosphorylation
2
2001
754
0.130
Why?
Neoplasms, Second Primary
1
2008
124
0.130
Why?
Point Mutation
1
2007
169
0.130
Why?
Fibroblasts
4
1986
514
0.130
Why?
Ethanol
1
2006
92
0.130
Why?
Gene Expression Profiling
1
2008
296
0.130
Why?
Plasma Cells
1
2005
24
0.130
Why?
Young Adult
4
2009
1013
0.120
Why?
Thalassemia
1
2005
21
0.120
Why?
Hispanic Americans
1
2005
86
0.120
Why?
Anemia, Sickle Cell
1
2005
46
0.120
Why?
Mutation
2
2001
1183
0.120
Why?
Ethnic Groups
1
2005
137
0.120
Why?
Calcium
2
2000
1069
0.120
Why?
Drug Therapy, Combination
2
1999
375
0.120
Why?
Enzyme Activation
2
2001
511
0.120
Why?
Radiotherapy, Adjuvant
2
1998
72
0.110
Why?
RNA, Messenger
3
1992
1791
0.110
Why?
Hemorrhage
1
2005
173
0.110
Why?
Histocompatibility
1
2003
14
0.110
Why?
Annexin A5
1
2003
16
0.110
Why?
Cell Line
3
1988
1554
0.110
Why?
Decision Support Techniques
1
2004
70
0.110
Why?
Severity of Illness Index
3
1993
878
0.110
Why?
Poly(ADP-ribose) Polymerases
1
2003
58
0.110
Why?
Gene Expression Regulation, Leukemic
2
1997
16
0.110
Why?
Histocompatibility Testing
3
2005
37
0.110
Why?
Blood Group Incompatibility
1
2003
37
0.110
Why?
Transplantation Immunology
1
2003
17
0.110
Why?
Feasibility Studies
1
2003
189
0.110
Why?
Interferon-gamma
2
1999
340
0.110
Why?
Vomiting
1
2003
114
0.110
Why?
Cell Culture Techniques
1
2003
86
0.100
Why?
Fetal Blood
1
2003
91
0.100
Why?
Leukocyte Count
2
1988
152
0.100
Why?
S Phase
2
1999
44
0.100
Why?
Chronic Disease
3
1993
496
0.100
Why?
Cell Death
3
2005
166
0.100
Why?
Pancytopenia
3
2001
13
0.100
Why?
Prospective Studies
3
1993
1606
0.100
Why?
Interleukins
2
1991
63
0.100
Why?
Nausea
1
2003
153
0.100
Why?
Pain Measurement
1
2003
241
0.100
Why?
Chemokines, CX3C
1
2001
9
0.100
Why?
Injections, Intravenous
1
2002
125
0.100
Why?
Leukopenia
2
1987
24
0.100
Why?
Chemokines, CC
1
2001
32
0.100
Why?
Chemokines, CXC
1
2001
49
0.100
Why?
Administration, Oral
1
2002
302
0.090
Why?
Syndrome
2
1991
203
0.090
Why?
Interleukin-8
1
2001
108
0.090
Why?
T-Lymphocytes
3
1991
546
0.090
Why?
Sweat Gland Diseases
1
2000
2
0.090
Why?
Oxidative Stress
2
1999
330
0.090
Why?
Chemokine CCL4
1
2000
21
0.090
Why?
Blood Grouping and Crossmatching
3
2000
32
0.090
Why?
Chemokine CCL3
1
2000
19
0.090
Why?
Regression Analysis
1
2002
489
0.090
Why?
Salvage Therapy
2
2009
56
0.090
Why?
Pain
1
2003
363
0.090
Why?
Lymphocyte Activation
2
1997
407
0.090
Why?
Pentoxifylline
1
2000
23
0.090
Why?
Kaplan-Meier Estimate
2
2010
190
0.090
Why?
HLA Antigens
3
2000
91
0.090
Why?
Tissue Donors
3
2000
69
0.090
Why?
Anemia, Aplastic
1
1999
25
0.090
Why?
Wiskott-Aldrich Syndrome
1
1999
9
0.080
Why?
Life Tables
1
1999
35
0.080
Why?
Diarrhea
1
1999
61
0.080
Why?
Penicillamine
1
1999
26
0.080
Why?
Partial Pressure
1
1999
51
0.080
Why?
Receptor Protein-Tyrosine Kinases
2
1995
76
0.080
Why?
Nitrites
1
1999
34
0.080
Why?
Corynebacterium Infections
1
1998
8
0.080
Why?
Proto-Oncogene Proteins c-kit
2
1995
15
0.080
Why?
Nitric Oxide Synthase Type II
1
1999
58
0.080
Why?
Infectious Mononucleosis
1
1998
21
0.080
Why?
Enzyme Induction
1
1999
153
0.080
Why?
Cause of Death
1
1999
155
0.080
Why?
Polymerase Chain Reaction
2
1993
586
0.080
Why?
Lysine
1
1999
70
0.080
Why?
HL-60 Cells
2
2007
47
0.080
Why?
Leukocyte Rolling
2
2007
16
0.080
Why?
Chemotaxis
1
1998
33
0.080
Why?
Neutropenia
1
1999
61
0.080
Why?
Patient Selection
1
1999
197
0.080
Why?
Nitric Oxide Synthase
1
1999
167
0.080
Why?
Aged, 80 and over
3
2006
2423
0.080
Why?
Receptors, Erythropoietin
1
1997
6
0.070
Why?
Leukocytes, Mononuclear
2
2007
109
0.070
Why?
Phagocytosis
1
1998
81
0.070
Why?
Monocytes
2
1988
294
0.070
Why?
Lipopolysaccharides
1
1999
208
0.070
Why?
Proto-Oncogene Proteins
2
1995
261
0.070
Why?
Globins
1
1997
50
0.070
Why?
Yolk Sac
1
1997
58
0.070
Why?
Receptors, Interleukin
1
1997
10
0.070
Why?
L-Selectin
1
1997
14
0.070
Why?
Reference Values
2
1991
427
0.070
Why?
Actins
1
1998
184
0.070
Why?
Connective Tissue
1
1997
43
0.070
Why?
Reactive Oxygen Species
1
1999
295
0.070
Why?
Proteoglycans
1
1997
89
0.070
Why?
Embryo, Mammalian
1
1997
181
0.070
Why?
Bucladesine
1
1996
40
0.070
Why?
RNA
1
2000
395
0.070
Why?
Extracellular Matrix Proteins
1
1997
74
0.070
Why?
Erythropoietin
1
1996
25
0.070
Why?
B-Lymphocyte Subsets
1
1997
67
0.070
Why?
Myeloablative Agonists
2
2000
6
0.070
Why?
DNA, Neoplasm
1
1996
127
0.070
Why?
Microscopy, Electron
1
1996
374
0.060
Why?
Receptors, Colony-Stimulating Factor
1
1995
1
0.060
Why?
Drug Administration Schedule
2
2003
362
0.060
Why?
Actuarial Analysis
2
1991
20
0.060
Why?
Chromosome Aberrations
2
2003
114
0.060
Why?
Gene Expression Regulation
1
2000
848
0.060
Why?
Vascular Cell Adhesion Molecule-1
1
1994
39
0.060
Why?
Umbilical Veins
1
1994
76
0.060
Why?
Leukemia, Experimental
1
1994
20
0.060
Why?
Ki-67 Antigen
1
1994
29
0.060
Why?
Treatment Failure
2
2001
125
0.060
Why?
In Situ Hybridization, Fluorescence
2
2002
107
0.060
Why?
Anemia
1
1994
76
0.060
Why?
Interleukin-4
2
1991
160
0.060
Why?
Rabbits
2
2005
686
0.060
Why?
Neoplasm Invasiveness
1
1994
150
0.060
Why?
Macrophage Colony-Stimulating Factor
1
1993
22
0.060
Why?
Anti-Inflammatory Agents, Non-Steroidal
2
2000
89
0.060
Why?
Intercellular Adhesion Molecule-1
1
1994
124
0.060
Why?
Recombinant Fusion Proteins
2
2002
375
0.050
Why?
Clinical Trials as Topic
1
1997
664
0.050
Why?
Lymphocytes
1
1994
293
0.050
Why?
Leukemia, Monocytic, Acute
1
1993
11
0.050
Why?
Tetradecanoylphorbol Acetate
1
1993
134
0.050
Why?
Platelet-Derived Growth Factor
1
1993
105
0.050
Why?
Risk Factors
3
2003
2172
0.050
Why?
Up-Regulation
1
1994
344
0.050
Why?
Immunoglobulins, Intravenous
1
1993
38
0.050
Why?
Infection
2
2000
66
0.050
Why?
Dexamethasone
1
1993
176
0.050
Why?
Megakaryocytes
1
1993
66
0.050
Why?
Sea Urchins
1
1992
16
0.050
Why?
Aniline Compounds
1
1992
22
0.050
Why?
Dogs
2
1995
465
0.050
Why?
Cell Count
2
2002
279
0.050
Why?
Injections, Intra-Arterial
1
2011
29
0.050
Why?
Leukemia, Myelomonocytic, Chronic
2
2001
18
0.050
Why?
Ribosomal Proteins
1
1992
41
0.050
Why?
RNA, Ribosomal
1
1992
67
0.050
Why?
Cytotoxicity Tests, Immunologic
1
1991
31
0.050
Why?
Disease Outbreaks
1
1992
109
0.050
Why?
Maximum Tolerated Dose
1
2010
16
0.050
Why?
Mucositis
1
2010
13
0.050
Why?
Proportional Hazards Models
2
1993
398
0.050
Why?
Medical Records
1
2011
122
0.050
Why?
Drug Resistance
1
2011
97
0.050
Why?
Neutralization Tests
1
1991
128
0.050
Why?
Plastics
1
1990
13
0.050
Why?
Cell Transformation, Neoplastic
1
2011
134
0.050
Why?
Thinness
1
2010
10
0.040
Why?
Nuclear Family
2
2000
13
0.040
Why?
Electrophysiology
1
1991
243
0.040
Why?
Overweight
1
2010
36
0.040
Why?
Antigens, Differentiation, B-Lymphocyte
1
1990
51
0.040
Why?
Gene Expression
1
1993
723
0.040
Why?
Chi-Square Distribution
1
1991
320
0.040
Why?
Vincristine
1
2009
57
0.040
Why?
Chemokine CXCL10
1
2009
23
0.040
Why?
Immobilized Proteins
1
2009
1
0.040
Why?
Pleurisy
1
2009
2
0.040
Why?
Atrial Fibrillation
1
2010
110
0.040
Why?
Clinical Trials, Phase II as Topic
1
2009
13
0.040
Why?
Cell Compartmentation
1
1989
56
0.040
Why?
Lymphoma, B-Cell, Marginal Zone
1
2009
10
0.040
Why?
Colitis
1
2009
24
0.040
Why?
Doxorubicin
1
2009
102
0.040
Why?
Lymphoproliferative Disorders
1
2009
30
0.040
Why?
Fibronectins
1
1990
144
0.040
Why?
Oligodeoxyribonucleotides
1
2009
138
0.040
Why?
Surface Properties
1
2009
158
0.040
Why?
Eosinophils
1
1988
46
0.040
Why?
Prednisone
1
2009
178
0.040
Why?
Cladribine
1
2008
6
0.040
Why?
Multicenter Studies as Topic
1
2009
126
0.040
Why?
Diagnosis, Differential
1
2011
855
0.040
Why?
Biopsy, Fine-Needle
1
2008
21
0.040
Why?
Comorbidity
1
2010
365
0.040
Why?
Triterpenes
1
2008
1
0.040
Why?
HIV Infections
1
1994
600
0.040
Why?
Data Interpretation, Statistical
1
2009
154
0.040
Why?
Binding Sites, Antibody
1
1988
33
0.040
Why?
Neoadjuvant Therapy
1
2008
30
0.040
Why?
Chemokine CCL2
1
2009
124
0.040
Why?
Terpenes
1
2008
16
0.040
Why?
Deoxycytidine
1
2008
26
0.040
Why?
Neoplasm Metastasis
1
2009
219
0.040
Why?
Cysteine Proteinase Inhibitors
1
2008
27
0.040
Why?
Chemotherapy, Adjuvant
1
2008
85
0.040
Why?
Cycloheximide
1
1988
84
0.040
Why?
Chromosomes, Human, Pair 8
1
2007
13
0.040
Why?
Physician's Practice Patterns
1
1991
223
0.040
Why?
Aldehydes
1
2008
27
0.040
Why?
Databases, Genetic
1
2008
26
0.040
Why?
Chromosomes, Human, Pair 21
1
2007
12
0.040
Why?
Xenograft Model Antitumor Assays
1
2008
43
0.040
Why?
Proteasome Endopeptidase Complex
1
2008
65
0.040
Why?
Saccharomyces cerevisiae Proteins
1
1992
261
0.040
Why?
Siblings
1
2007
35
0.040
Why?
fms-Like Tyrosine Kinase 3
1
2007
4
0.040
Why?
Antigens, Human Platelet
1
2007
8
0.040
Why?
Receptors, IgG
1
1988
67
0.040
Why?
Exons
1
2008
165
0.040
Why?
Biological Availability
1
2007
39
0.040
Why?
Leukocyte Reduction Procedures
1
2007
13
0.040
Why?
Culture Media, Conditioned
1
2007
60
0.040
Why?
Drug Design
1
2007
45
0.040
Why?
Models, Genetic
1
2008
157
0.040
Why?
Sulfhydryl Compounds
1
2007
71
0.040
Why?
Thrombocytosis
1
1987
5
0.040
Why?
Centromere
1
2007
10
0.040
Why?
Chromosome Banding
1
2007
29
0.040
Why?
Leukocytosis
1
1987
18
0.040
Why?
Tumor Markers, Biological
1
2009
221
0.040
Why?
HSP40 Heat-Shock Proteins
1
2006
6
0.040
Why?
Hematocrit
1
1987
109
0.030
Why?
Endothelium
1
1986
55
0.030
Why?
Structure-Activity Relationship
1
2007
307
0.030
Why?
Data Collection
1
2007
201
0.030
Why?
Drinking Behavior
1
2006
9
0.030
Why?
Forensic Medicine
1
2006
8
0.030
Why?
Proteins
1
2009
435
0.030
Why?
Tumor Suppressor Protein p53
1
2007
134
0.030
Why?
Oligonucleotide Array Sequence Analysis
1
2008
278
0.030
Why?
Postoperative Complications
1
2010
706
0.030
Why?
DNA Nucleotidylexotransferase
2
1994
15
0.030
Why?
Immunohistochemistry
1
2009
1024
0.030
Why?
Protein Kinase C
1
2007
193
0.030
Why?
Antibodies, Neoplasm
1
2005
39
0.030
Why?
Risk
1
2006
343
0.030
Why?
Immunoglobulin Fab Fragments
1
2005
31
0.030
Why?
Immunoglobulin G
1
2007
491
0.030
Why?
Minority Groups
1
2005
52
0.030
Why?
Cell Membrane
1
2007
474
0.030
Why?
Hemoglobinopathies
1
2005
8
0.030
Why?
Drug Synergism
1
2005
149
0.030
Why?
Sensitivity and Specificity
1
2008
866
0.030
Why?
Reproducibility of Results
1
2008
859
0.030
Why?
Radiation-Protective Agents
1
2004
38
0.030
Why?
Gene Expression Regulation, Developmental
2
1997
329
0.030
Why?
Tomography, X-Ray Computed
1
2008
729
0.030
Why?
Markov Chains
1
2004
40
0.030
Why?
Logistic Models
1
2006
581
0.030
Why?
Cytogenetics
1
2003
14
0.030
Why?
NF-kappa B
1
2007
405
0.030
Why?
Blood Transfusion
1
2005
166
0.030
Why?
Statistics, Nonparametric
1
2004
251
0.030
Why?
Microscopy, Phase-Contrast
1
2002
15
0.030
Why?
Vascular Endothelial Growth Factor Receptor-1
1
2002
10
0.030
Why?
Odds Ratio
1
2003
301
0.030
Why?
Protein Prenylation
1
2001
4
0.020
Why?
Genes, ras
1
2001
34
0.020
Why?
Questionnaires
1
2006
942
0.020
Why?
Mitoxantrone
1
2001
20
0.020
Why?
Anemia, Refractory, with Excess of Blasts
1
2001
9
0.020
Why?
Disease Progression
1
2003
496
0.020
Why?
Hyperbilirubinemia
1
2001
13
0.020
Why?
Mitogen-Activated Protein Kinase 3
1
2001
87
0.020
Why?
Randomized Controlled Trials as Topic
1
2003
400
0.020
Why?
Drug-Induced Liver Injury
1
2001
35
0.020
Why?
Mitogen-Activated Protein Kinase 1
1
2001
90
0.020
Why?
Graft vs Leukemia Effect
1
2000
8
0.020
Why?
Infant, Newborn
1
2005
1772
0.020
Why?
Necrosis
1
2000
99
0.020
Why?
Drug Toxicity
1
2000
14
0.020
Why?
Drug Evaluation
1
2000
98
0.020
Why?
Mitogen-Activated Protein Kinases
1
2001
174
0.020
Why?
Evaluation Studies as Topic
1
2000
240
0.020
Why?
Placebos
1
2000
177
0.020
Why?
DNA Replication
1
2001
189
0.020
Why?
Bone Marrow Examination
1
1998
25
0.020
Why?
Behavior Therapy
1
2000
95
0.020
Why?
Base Sequence
2
1992
1681
0.020
Why?
Signal Transduction
1
2007
1465
0.020
Why?
Molecular Sequence Data
2
1992
1993
0.020
Why?
United States
1
2005
2511
0.020
Why?
Mice, Inbred ICR
1
1997
80
0.020
Why?
Oligonucleotides, Antisense
1
1997
48
0.020
Why?
Organ Culture Techniques
1
1997
98
0.020
Why?
Erythroblasts
1
1997
40
0.020
Why?
Neoplasm, Residual
1
1997
21
0.020
Why?
Embryonic and Fetal Development
1
1997
95
0.020
Why?
Receptors, Interleukin-7
1
1997
4
0.020
Why?
Antigens, CD19
1
1997
13
0.020
Why?
Double-Blind Method
1
2000
985
0.020
Why?
Antigens, CD45
1
1997
39
0.020
Why?
Clone Cells
1
1997
188
0.020
Why?
Multivariate Analysis
1
1997
487
0.020
Why?
Immunomagnetic Separation
1
1994
7
0.020
Why?
Radiation Dosage
1
1995
115
0.010
Why?
Growth Inhibitors
1
1994
35
0.010
Why?
Radiation Tolerance
1
1995
78
0.010
Why?
Chromatography, Affinity
1
1994
89
0.010
Why?
HIV
1
1994
73
0.010
Why?
Autoantibodies
1
1994
109
0.010
Why?
Radiotherapy
1
1995
179
0.010
Why?
Ectoderm
1
1992
12
0.010
Why?
Endoderm
1
1992
11
0.010
Why?
RNA Probes
1
1992
22
0.010
Why?
Oogenesis
1
1992
8
0.010
Why?
Larva
1
1992
44
0.010
Why?
Embryo, Nonmammalian
1
1992
45
0.010
Why?
Age Factors
1
1995
1060
0.010
Why?
Nucleic Acid Hybridization
1
1992
176
0.010
Why?
Cytoplasm
1
1992
198
0.010
Why?
Models, Biological
1
1994
982
0.010
Why?
Amino Acid Sequence
1
1992
1198
0.010
Why?
Transcription, Genetic
1
1992
795
0.010
Why?
Saccharomyces cerevisiae
1
1992
381
0.010
Why?

Visualizations


Liesveld's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department